Lupin Biologics Limited, a active public limited company, was established on 28 January 2021 in Mumbai, Maharashtra, India. Engaging in biotechnology within the life sciences sector, it holds CIN: U24299MH2021PLC354211. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹10.00 Cr and a paid-up capital of ₹1.50 M.
Its leadership includes Swaminathan Ramesh (Director), Nilesh Deshbandhu Gupta (Director), Vinita Deshbandhu Gupta (Director). Its latest AGM occurred on 30 July 2025, with the balance sheet filed on 31 March 2025. It is based at Kalpataru Inspire, 3Rd Floor, Off Western Express Highway, Santacruz East, Mumbai, Maharashtra, 400055.
U24299MH2021PLC354211
354211
28 January 2021
₹10.00 Cr
₹1.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Lupin Biologics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swaminathan Ramesh | Director | 28 Jan 2021 | Current |
| Nilesh Deshbandhu Gupta | Director | 28 Jan 2021 | Current |
| Vinita Deshbandhu Gupta | Director | 28 Jan 2021 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Lupin Biologics Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 94.51% increase in profit. The company's net worth observed a substantial decline by a decrease of 37.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Lupin Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Lupin Biologics has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Lupin Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lupin Biologics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Lupin Biologics Limited last Annual general meeting of members was held on 30 Jul 2025 as per latest MCA records. was completed.
Lupin Biologics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Swaminathan Ramesh was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Nilesh Deshbandhu Gupta was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
Vinita Deshbandhu Gupta was appointed as a Director was appointed as a Director on 28 Jan 2021 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
The activity Lupin Biologics Limited was registered on 28 Jan 2021 with Roc Mumbai & aged 4 years 11 months as per MCA records. was completed.
Funke has previously worked in leadership roles at organisations such as Fresenius Kabi and Strides Pharma Science. In his leadership roles, Funke has managed large-scale technical operations and manufacturing networks across 27 sites in 19 countries, overseeing production value exceeding $ 2 billion and leading teams of over 12,500 employees, the press release said. Funke holds an engineering degree from South Westphalia University of Applied Sciences, Germany..
The product is a generic equivalent of AstraZeneca AB's Qtern tablets.
Whether Johnny Mikell will be given enough authority to steer the ship will be an important factor, say analysts.Resolving the issues soon will be crucial for the company, considering that further delays would make it more prominent on US FDA’s heat map.
The CIN of Lupin Biologics Limited is U24299MH2021PLC354211.
Lupin Biologics Limited is headquartered at Kalpataru Inspire, 3Rd Floor, Off Western Express Highway, Santacruz East, Mumbai, Maharashtra, 400055.
Lupin Biologics Limited was incorporated on 28 January 2021.
The current directors of Lupin Biologics Limited are
The primary industry of Lupin Biologics Limited is Life Sciences.
Lupin Biologics Limited is unlisted.
The authorized capital of Lupin Biologics Limited is ₹10.00 Cr, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX